Lee Financial’s Biogen BIIB Stock Holding History

Lee Financial’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2	Closed	-$518	–	229
2023 Q4	$518	Sell	2 -6	-75%	-$1.47K	﹤0.01%	823
2023 Q3	$2.06K	Hold	8	–	–	﹤0.01%	675
2023 Q2	$2.28K	Hold	8	–	–	﹤0.01%	637
2023 Q1	$2.23K	Sell	8 -2	-20%	-$553	﹤0.01%	654
2022 Q4	$2.77K	Hold	10	–	–	﹤0.01%	635
2022 Q3	$3K	Buy	10 +8	+400%	+$1.7K	﹤0.01%	604
2022 Q2	$0	Buy	+2	New	+$409	﹤0.01%	864
2021 Q3	–	Sell	-8	Closed	-$3K	–	697
2021 Q2	$3K	Buy	+8	New	+$2.42K	﹤0.01%	501
2020 Q1	–	Sell	-18	Closed	-$5K	–	482
2019 Q4	$5K	Hold	18	–	–	﹤0.01%	408
2019 Q3	$4K	Hold	18	–	–	﹤0.01%	431
2019 Q2	$4K	Hold	18	–	–	﹤0.01%	436
2019 Q1	$4K	Buy	+18	New	+$5.67K	﹤0.01%	420
2018 Q3	–	Sell	-10	Closed	-$3K	–	495
2018 Q2	$3K	Buy	10 +9	+900%	+$2.53K	﹤0.01%	676
2018 Q1	$0	Buy	+1	New	+$310	﹤0.01%	748

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lee Financial's BIIB Position: Q1 2024 in Review

Lee Financial sold out of Biogen (BIIB) in Q1 2024, closing a stake of 2 shares — an estimated $518 sold.

Lee Financial first reported a position in BIIB in Q1 2018 and held it in 14 quarters. The position peaked at $5K in Q4 2019. 955 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

Lee Financial reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
Lee Financial sold 2 Biogen shares in Q1 2024, an estimated $518.
Lee Financial first reported a position in Biogen in Q1 2018 and held it in 14 quarters.
Lee Financial's Biogen position peaked at $5K in Q4 2019.
955 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Lee Financial's 13F filing for Q1 2024, filed 15 May 2024.